Doctor profile · Federal record
Dr. Akilah Bryant, R.N.
Adult Health Nurse Practitioner · New York, NY
- NPI 1336460930
- 16 yrs on file
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
160 E 34Th St
New York, NY 100164744
(212) 731-5348
Credentials & registration
- NPI registered
- June 2010 — 16 yrs on file
- Profile last updated
- December 27, 2017
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- New York #F306867-1
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336460930. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$1,040
Transactions
35
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Daiichi Sankyo Inc. | 23 | $512.18 | |
| Stemline Therapeutics Inc. | 4 | $211.63 | |
| Gilead Sciences, Inc. | 1 | $145.91 | |
| Novartis Pharmaceuticals Corporation | 3 | $76.87 | |
| Alexion Pharmaceuticals, Inc. | 1 | $28.46 | |
| PFIZER INC. | 1 | $28.41 | |
| Amgen Inc. | 1 | $19.57 | |
| AstraZeneca Pharmaceuticals LP | 1 | $16.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
130
Patients
45
Total drug cost
$286,281
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 62 | 28 | $1,396 |
| Letrozole | Generic | 34 | 17 | $1,014 |
| Ibrance (Palbociclib) | Brand | 18 | 0 | $283,673 |
| Ondansetron Odt (Ondansetron) | Brand | 16 | 0 | $198 |
Frequently asked questions
What is Dr. Akilah Bryant's medical specialty?
Dr. Akilah Bryant practices Adult Health Nurse Practitioner in New York, NY.
Where does Dr. Akilah Bryant practice?
Dr. Akilah Bryant practices at 160 E 34Th St, New York, NY 100164744. Office phone: 2127315348.
What is Dr. Akilah Bryant's NPI?
Dr. Akilah Bryant's National Provider Identifier (NPI) is 1336460930, issued by NPPES.